BOSTON PHARMACEUTICALS Trademark

Trademark Overview


On Wednesday, December 20, 2023, a trademark application was filed for BOSTON PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the BOSTON PHARMACEUTICALS trademark a serial number of 98323673. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, October 30, 2024. This trademark is owned by Boston Pharmaceuticals, Inc.. The BOSTON PHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
boston pharmaceuticals

General Information


Serial Number98323673
Word MarkBOSTON PHARMACEUTICALS
Filing DateWednesday, December 20, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Description of MarkThe mark consists of the word "BOSTON" in stylized capital letters above the word "PHARMACEUTICALS" also in stylized letters and to the right consists of a tree design.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BOSTON PHARMACEUTICALS"
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 20, 2023
Primary Code042
First Use Anywhere DateMonday, December 4, 2023
First Use In Commerce DateMonday, December 4, 2023

Trademark Owner History


Party NameBoston Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameBoston Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Wednesday, December 20, 2023NEW APPLICATION ENTERED
Saturday, April 13, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, April 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 24, 2024NON-FINAL ACTION WRITTEN
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Friday, May 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 24, 2024NON-FINAL ACTION E-MAILED
Friday, May 24, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 28, 2024USE AMENDMENT FILED
Wednesday, August 28, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, October 29, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 29, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 30, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 30, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED